RECRUITING

Impaired Interlimb Coordination During Locomotion in Individuals With Chronic Stroke: Contributors and Effect on Walking Function

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Individuals with chronic stroke have long-term walking problems that limit community engagement and quality of life, lead to secondary disabilities, and increase healthcare costs and burden. These walking issues often persist despite rehabilitation. One novel target for stroke gait rehabilitation is interlimb coordination-the phase-dependent cyclical relation of the legs. Interlimb coordination is altered during walking after stroke, compromising walking stability, phase transitions, and responses to perturbation and contributing to motor compensation. It is unclear what neural pathways contribute to impaired interlimb coordination after stroke and what impact this has on walking-related outcomes. This proposal consists of two aims to address these issues, with the long-term goal of developing therapeutic interventions to improve interlimb coordination and walking after stroke. Aim 1 will identify which neural sources contribute to impaired interlimb coordination after stroke. During bilateral, cyclical recumbent stepping (analogue of walking), interlimb coordination will be assessed as relative leg phasing. During the task, transcranial magnetic stimulation and peripheral nerve stimulation will be applied to assess supraspinal, interhemispheric, spinal interneuronal, and sensory pathways. The relation of interlimb coordination with these outcomes will be assessed to determine potential contributors. Aim 2 will test the association between interlimb coordination and walking after stroke. Interlimb coordination will be quantified during split-belt treadmill walking, and associations with walking speed, endurance, mobility, independence, daily activity, quality of life, and community engagement will be tested. An additional exploratory aim will determine the effect of targeted neuromodulation on lower limb interlimb coordination. Electrical stimulation will be applied to three locations in a cross-over study: the primary motor cortex (supraspinal/interhemispheric), thoracolumbar spine (spinal interneuronal), and peripheral nerves (sensory).

Official Title

Impaired Interlimb Coordination During Locomotion in Individuals With Chronic Stroke: Contributors and Effect on Walking Function

Quick Facts

Study Start:2025-09-15
Study Completion:2028-04-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT07006818

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:25 Years to 90 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Age: 25 - 90 years of age
  2. * Monohemispheric stroke
  3. * Chronic phase (\> 6 months post stroke)
  4. * Ability to walk for at least 6 minutes at a self-selected comfortable speed
  1. * Lesions affecting the brainstem or cerebellum
  2. * Other neurological disorders
  3. * Current botox treatments for the lower limb
  4. * Significant cognitive or communication impairment
  5. * Previous adverse reaction to TMS
  6. * Skull abnormalities or fractures
  7. * Concussion within the prior 6 months
  8. * Unexplained, recurring headaches
  9. * Implanted cardiac pacemaker
  10. * Metal implants in the head or face
  11. * History of seizures or epilepsy
  12. * Use of medications that could increase risk of seizure
  13. * Current pregnancy
  14. * Skin hypersensitivity at any sites of stimulation, including the scalp, thoracolumbar spine, and peripheral limbs
  15. * History of contact dermatitis at any of the sites of stimulation
  16. * History of allodynia and/or hyperalgesia
  17. * Active skin infection
  18. * Skin lesions
  19. * Deep vein thrombosis
  20. * Any other skin or scalp condition that could be aggravated by stimulation
  21. * Implanted electronic, metallic, or highly conductive devices near site of stimulation that cannot be removed without permission from a health professional

Contacts and Locations

Study Contact

Brice T Cleland, PhD
CONTACT
3129969056
bcleland@uic.edu

Study Locations (Sites)

University of Illinois at Chicago
Chicago, Illinois, 60612
United States

Collaborators and Investigators

Sponsor: University of Illinois at Chicago

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-09-15
Study Completion Date2028-04-30

Study Record Updates

Study Start Date2025-09-15
Study Completion Date2028-04-30

Terms related to this study

Additional Relevant MeSH Terms

  • Stroke